/ Home / News / Company News /

Risk Warning: Beware of Unauthorized Business Under SENOVA’s Name

Risk Warning: Beware of Unauthorized Business Under SENOVA’s Name

Release Time: 2026-06-23

News Source: SENOVA TECHNOLOGY CO., LTD Official Release

Author: Operation Dept.

Risk Warning: Beware of Unauthorized Business Under SENOVA’s Name(图1)Official Formal Statement-20260623.pdf

Official Formal Statement

Official Full Company Profile for Authentication

Full English Name: SENOVA TECHNOLOGY CO., LTD

Full Chinese Name: 深圳尚诺生物科技有限公司

D-U-N-S Number: 418 616 356

Address: Room 1909, Tower A, Shangmei International Building, 1355 Liuxian Avenue, Nanshan District, Shenzhen, China, Post Code: 518055

Tel: +86-755-3337 2138 / 3337 2139

Official Website: www.senovatech.com

 

To safeguard the legitimate rights and interests of our global partners and standardize market operation, we hereby issue this formal statement as follows:

 

1. Exclusive Legal Entity Confirmation

Only the enterprise with the full name, registered address, D-U-N-S number and contact information listed above is the authentic SENOVA entity. Any entity or individual with similar names, inconsistent addresses or unauthorized contact information has no shareholding, business or authorized relationship with our company. All their commercial activities shall not be deemed representative of SENOVA TECHNOLOGY CO., LTD, and we shall bear no corresponding commercial or legal liabilities.

 

2. Compliant Business Scope Notice

SENOVA TECHNOLOGY CO.,LTD focuses on fully compliant global pharmaceutical raw material trade, with GLP-1 API as our core product line.

Important Restriction: For countries and regions under patent protection restrictions, we only supply GLP-1 API exclusively for laboratory research purposes.

We never distribute any other forms of GLP-1 products, including finished formulations, peptide solutions, lyophilized vials or injectable finished drugs. No finished or repackaged GLP-1 products are available from our company.

 

3. Warning Against Unauthorized Impersonation & Official Verification Channels

Recently, certain third-party individuals and organizations have illegally used the "SENOVA" brand and our corporate name to conduct irregular commercial activities, which may mislead clients and bring severe transaction & customs compliance risks.

Before proceeding with any cooperation, quotation or supply offers claiming to be from SENOVA, please verify authenticity via our exclusive official channels:

① Official Website: www.senovatech.com

② Official Verification Email: info@senovatech.com

③ Official Landline: +86-755-3337 2138 / 3337 2139

 

4. Legal Liability Reservation

We have fully collected evidence against any parties that illegally impersonate our company name and brand for business operation. We reserve all rights to pursue full civil, administrative and even criminal liabilities through regulatory authorities and legal counsel, both domestically and cross-border. All global partners are reminded to strictly verify counterpart information to prevent financial losses and import/export compliance violations.

 

Issued by: SENOVA TECHNOLOGY CO., LTD

Date: 2026.06.23

 

 

 

 

 

 

 

 

 

官方严正声明

一、官方唯一核验主体信息

公司英文全称:SENOVA TECHNOLOGY CO., LTD

公司中文全称:深圳尚诺生物科技有限公司

邓白氏编码:418 616 356

公司地址:中国深圳市南山区留仙大道1355号尚美国际大厦A座1909室,邮编518055

联系电话:+86-755-3337 2138 / 3337 2139

官方网站:www.senovatech.com

 

为维护全球合作伙伴合法权益、规范市场经营秩序,我司现就主体资质、业务范围及防假冒事宜郑重声明如下:

 

二、唯一合法经营主体说明

上述完整名称、注册地址、邓白氏编码及联系方式对应的企业,为我司唯一合法官方主体。任何名称相似、地址不符、联系方式不一致的机构或个人,均与深圳尚诺生物科技有限公司无任何股权、合作及授权关系。其所有经营行为均与我司无关,我司不承担任何法律及连带责任。

 

三、合规业务范围说明

我司专注全球合规医药原料药进出口业务,核心经营产品为GLP-1原料药(API)。

重要合规说明:针对存在专利保护的国家及地区,我司GLP-1产品仅作科研研发用途销售,不面向临床及终端使用。

我司不销售GLP-1制剂、注射液、肽液、冻干粉、成品药剂及一切分装成品类产品,无任何成品供货业务。

 

四、真伪核验官方渠道(谨防冒用)

近期市场出现部分个人及机构冒用我司“SENOVA”品牌、假借我司名义开展违规业务,严重扰乱市场秩序、误导海内外客户。所有合作、报价、供货信息,务必通过以下官方渠道核验真伪:

① 官方网站:www.senovatech.com

② 官方核验邮箱:info@senovatech.com

③ 官方固定电话:+86-755-3337 2138 / 3337 2139

 

五、法律责任保留声明

针对一切冒用我司名称、品牌、资质进行虚假宣传及商业欺诈的侵权行为,我司已固定全部证据。我司将依法追究侵权方全部民事、行政及刑事责任,绝不姑息。请海内外合作客户严格核验合作主体,规避交易风险、合规风险及财产损失。

 

出具单位:深圳尚诺生物科技有限公司

日期:2026年06月23日